Viewing Study NCT06821503


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2026-01-02 @ 7:31 AM
Study NCT ID: NCT06821503
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-02-17
First Post: 2025-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module